نتائج البحث - Anastasios Stathis

تنقيح النتائج
  1. 1
    An overview on anti-tubulin agents for the treatment of lymphoma patients

    An overview on anti-tubulin agents for the treatment of lymphoma patients حسب Marilia Barreca, Anastasios Stathis, Paola Barraja, Francesco Bertoni

    منشور في 2020
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Radiomics in cervical and endometrial cancer

    Radiomics in cervical and endometrial cancer حسب Lucia Manganaro, Gabriele Maria Nicolino, Miriam Dolciami, Federica Martorana, Anastasios Stathis, Ilaria Colombo, Stefania Rizzo

    منشور في 2021
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type

    Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type حسب Anastasios Stathis, Claudio Chini, Francesco Bertoni, Ilaria Proserpio, C. Capella, Luca Mazzucchelli, E Pedrinis, Franco Cavalli, G. Pinotti, Emanuele Zucca

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I study

    Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-esca... حسب Anastasios Stathis, Ian W. Flinn, Sumit Madan, Kami J. Maddocks, Arnold S. Freedman, Steven Weitman, Emanuele Zucca, Mihaela Munteanu, M. Lia Palomba

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Incidence, risk factors and outcome of histological transformation in follicular lymphoma

    Incidence, risk factors and outcome of histological transformation in follicular lymphoma حسب Annarita Conconi, Carlotta Ponzio, Chiara Lobetti‐Bodoni, Maddalena Motta, Paola M. V. Rancoita, Anastasios Stathis, Alden A. Moccia, Luca Mazzucchelli, Francesco Bertoni, Michele Ghielmini, Franco Cavalli, Emanuele Zucca

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Histologic transformation in marginal zone lymphomas

    Histologic transformation in marginal zone lymphomas حسب Annarita Conconi, Silvia Franceschetti, Kathrin Aprile von Hohenstaufen, Gloria Margiotta‐Casaluci, Anastasios Stathis, Alden A. Moccia, Francesco Bertoni, Antonio Ramponi, Luca Mazzucchelli, Franco Cavalli, Gianluca Gaïdano, Emanuele Zucca

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628

    Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628 حسب Anastasios Stathis, Emanuele Zucca, Mohamed Békradda, Carlos Gomez‐Roca, Jean‐Pierre Delord, Thibault De La Motte Rouge, Emmanuelle Uro‐Coste, Filippo de Braud, Giuseppe Pelosi, Christopher A. French

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Prognostic impact of monocyte count at presentation in mantle cell lymphoma

    Prognostic impact of monocyte count at presentation in mantle cell lymphoma حسب Kathrin Aprile von Hohenstaufen, Annarita Conconi, Cassio P. de Campos, Silvia Franceschetti, Francesco Bertoni, Gloria Margiotta Casaluci, Anastasios Stathis, Michele Ghielmini, Georg Stüssi, Franco Cavalli, Gianluca Gaïdano, Emanuele Zucca

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Pembrolizumab in relapsed or refractory Richter syndrome

    Pembrolizumab in relapsed or refractory Richter syndrome حسب Philippe Armand, Niels Murawski, Daniel Molin, Jasmine Zain, Barbara Eichhorst, Zafer Gülbaş, Eliza A. Hawkes, John M. Pagel, Tycel Phillips, Vincent Ribrag, Jakub Svoboda, Anastasios Stathis, Arkendu Chatterjee, Robert Orlowski, Patricia Marinello, Beth Christian

    منشور في 2020
    احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma

    Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma حسب Luca Ceriani, Lisa Milan, Maurizio Martelli, Andrés J.M. Ferreri, Luciano Cascione, Pier Luigi Zinzani, Alice Di Rocco, Annarita Conconi, Anastasios Stathis, Franco Cavalli, Monica Bellei, Kelly Cozens, Elena Porro, Luca Giovanella, Peter Johnson, Emanuele Zucca

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model

    SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model حسب Luca Ceriani, Giuseppe Gritti, Luciano Cascione, Maria Cristina Pirosa, Angela Polino, Teresa Ruberto, Anastasios Stathis, Andrea Bruno, Alden A. Moccia, Luca Giovanella, Stefanie Hayoz, Sämi Schär, Stefan Dirnhofer, Alessandro Rambaldi, Giovanni Martinelli, Christoph Mamot, Emanuele Zucca

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase 2 LOTIS-2 study

    Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: long-term efficacy and safety from the phase 2 LOTIS-2 study حسب Paolo F. Caimi, Weiyun Z. Ai, Juan Pablo Alderuccio, Kirit M. Ardeshna, Mehdi Hamadani, Brian T. Hess, Brad S. Kahl, John Radford, Melhem Solh, Anastasios Stathis, Pier Luigi Zinzani, Ying Wang, Yajuan Qin, Luqiang Wang, Zhiying Cindy Xu, Carmelo Carlo‐Stella

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs

    The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs حسب Michela Boi, Eugenio Gaudio, Paola Bonetti, Ivo Kwee, Elena Bernasconi, Chiara Tarantelli, Andrea Rinaldi, Monica Testoni, Luciano Cascione, Maurilio Ponzoni, Afua A. Mensah, Anastasios Stathis, Georg Stüssi, María E. Riveiro, Patrice Herait, Giorgio Inghirami, Esteban Cvitkovic, Emanuele Zucca, Francesco Bertoni

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models

    The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models حسب Stuart W. Hicks, Chiara Tarantelli, Alan Wilhem, Eugenio Gaudio, Min Li, Alberto J. Arribas, Filippo Spriano, Roberta Bordone, Luciano Cascione, Katharine C. Lai, Qifeng Qiu, Monica Taborelli, Davide Rossi, Georg Stüssi, Emanuele Zucca, Anastasios Stathis, Callum M. Sloss, Francesco Bertoni

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

    Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734 حسب Filippo Spriano, Eugenio Gaudio, Luciano Cascione, Chiara Tarantelli, Federica Melle, Giovanna Motta, Valdemar Priebe, Andrea Rinaldi, Gaetanina Golino, Afua A. Mensah, Luca Aresu, Emanuele Zucca, Stefano Pileri, Michael Witcher, B. Brown, Claes Wahlestedt, Francis J. Giles, Anastasios Stathis, Francesco Bertoni

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors

    A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected... حسب Philippe L. Bédard, Josep Tabernero, Filip Janků, Zev A. Wainberg, Luis Paz‐Ares, Johan Vansteenkiste, Eric Van Cutsem, José Manuel Pérez-García, Anastasios Stathis, Carolyn D. Britten, Ngocdiep T. Le, Kirsten Carter, David Demanse, Dénes Csonka, Malte Peters, Angela Zubel, Heidi Nauwelaerts, Cristiana Sessa

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas

    Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas حسب Anastasios Stathis, Sébastien J. Hotte, Eric X. Chen, Holger W. Hirte, Amit M. Oza, Patrícia Moretto, Sheila Webster, Anne Laughlin, Lee-Anne Stayner, Shauna McGill, Lisa Wang, Wenjiang Zhang, Igor Espinoza‐Delgado, Julianne L. Holleran, Merrill J. Egorin, Lillian L. Siu

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models

    Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models حسب Chiara Tarantelli, Martin Lange, Eugenio Gaudio, Luciano Cascione, Filippo Spriano, Ivo Kwee, Alberto J. Arribas, Andrea Rinaldi, Thibaud Jourdan, Melanie Berthold, Andrea Sturz, Carolyn Sperl, Francesco Margheriti, Lorenzo Scalise, Giuseppe Gritti, Davide Rossi, Anastasios Stathis, Ningshu Liu, Emanuele Zucca, Oliver Politz, Francesco Bertoni

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

    Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma حسب Luca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, Andrés J.M. Ferreri, Barbara Botto, Caterina Stelitano, Manuel Gotti, Maria Giuseppina Cabras, Luigi Rigacci, Livio Gargantini, Francesco Merli, Graziella Pinotti, Donato Mannina, Stefano Luminari, Anastasios Stathis, Eleonora Russo, Franco Cavalli, Luca Giovanella, Peter Johnson, Emanuele Zucca

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)

    A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575) حسب Suzanne Richter, Philippe L. Bédard, Eric Xueyu Chen, Blaise Clarke, Ben Tran, Sébastien J. Hotte, Anastasios Stathis, Hal W. Hirte, Albiruni R. Abdul Razak, Michael Reedijk, Zhuo Chen, Brenda Cohen, Wenjiang Zhang, Lisa Wang, S. Percy Ivy, Malcolm J. Moore, Amit M. Oza, Lillian L. Siu, Elaine McWhirter

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: